Welcome to our dedicated page for Accolade news (Ticker: ACCD), a resource for investors and traders seeking the latest updates and insights on Accolade stock.
Accolade, Inc. reports developments for its personalized healthcare platform, which combines virtual primary care, mental health support, expert medical opinion services, and care navigation for employer, health plan, and consumer markets. Company updates often center on PlushCare, direct-to-consumer virtual healthcare access, Medicare Part B acceptance, and services aimed at primary care, clinical weight management, and behavioral health support.
Recurring ACCD news also covers operating and financial results, investor presentations, material agreements, shareholder voting matters, governance, capital-structure disclosures, and healthcare regulatory topics tied to Accolade's virtual care and navigation model.
Accolade, Inc. (NASDAQ: ACCD) will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1, 2020. This event includes a fireside chat presentation. Participants can access an audio replay and related materials on ir.accolade.com. Accolade provides personalized health solutions that empower individuals to navigate the healthcare system effectively, boasting consumer satisfaction ratings over 90% and a net promoter score of 60.
Accolade, Inc. (NASDAQ: ACCD) will participate in the virtual 29th Annual Credit Suisse Healthcare Conference on November 11, 2020, at 10:15 a.m. E.T. The event includes a fireside chat presentation. Audio webcast and materials will be available on their investor relations website. Accolade offers personalized health solutions using technology to help users navigate healthcare and benefits with ease, maintaining over 90% consumer satisfaction and an NPS of 60.
Accolade, Inc. (Nasdaq: ACCD) announced the closing of its public offering of 5,750,000 shares of common stock at $38.50 per share, raising approximately $221.4 million in gross proceeds. This includes the full exercise of the underwriters' option to purchase an additional 750,000 shares. The offering was managed by Goldman Sachs, Morgan Stanley, and BofA Securities, among others. The funds will support Accolade's growth in personalized health solutions, aiding individuals in navigating the healthcare system.
Accolade, Inc. announced a public offering of 5,000,000 shares of common stock priced at $38.50 each, with an anticipated closing date of October 26, 2020. The underwriters have an option to purchase an additional 750,000 shares. Proceeds will be allocated for general corporate purposes, including working capital, operating expenses, and strategic investments. Goldman Sachs, Morgan Stanley, and BofA Securities are the joint book-running managers for the offering.
Accolade has filed a registration statement with the SEC for a public offering of 4,500,000 shares of common stock, with an option for underwriters to purchase an additional 675,000 shares. The offering price is yet to be determined and is subject to market conditions. Proceeds will be used for general corporate purposes including working capital, operating expenses, and strategic investments. Joint book-running managers include Goldman Sachs, Morgan Stanley, and BofA Securities. The registration statement is pending effectiveness.
Accolade, Inc. reported fiscal Q2 2021 revenue of $36.8 million, reflecting a 24% increase from $29.7 million in Q2 2020, fueled by rising customer additions across various segments. Despite ongoing challenges from the COVID-19 pandemic, CEO Rajeev Singh emphasized the company's strong financial performance and positive momentum. Notably, adjusted gross profit grew 23% to $15.9 million. However, the company experienced a net loss of $15.4 million, slightly higher than the previous year's $15 million loss. The outlook for the full year has been raised, indicating confidence in future growth.
Summary not available.
Accolade (NASDAQ: ACCD) will release its fiscal Q2 2021 financial results on October 14, 2020, after markets close. The company will host a conference call at 5:00 p.m. EDT on the same day to discuss the results. Accolade offers personalized health solutions, assisting users in navigating the healthcare system and workplace benefits. The company boasts over 90% consumer satisfaction and a Net Promoter Score of 60, emphasizing its commitment to enhancing healthcare experiences.
Summary not available.
Accolade, Inc. (NASDAQ: ACCD) will participate in the virtual Morgan Stanley 18th Annual Healthcare Conference on September 14, 2020, at 1:30 p.m. E.T. The event will include a fireside chat presentation, and an audio webcast along with related materials will be accessible at ir.accolade.com.
Accolade offers personalized health and benefits solutions aimed at helping users navigate the healthcare system more effectively. The company boasts high consumer satisfaction ratings, exceeding 90%, and a Net Promoter Score (NPS) of 60.